Breaking Company Profile, Contacts & Intelligence

Biotechnology ResearchBoston, Massachusetts, United States30 employeesFounded 2024
2 contacts with email or phone data2 with email data2 with phone data
Employees
30
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts

Breaking Overview

Breaking is a plastic degradation company gestated at Colossal Biosciences that uses synthetic biology. Its flagship product, X-32 was discovered in 2022 at the Wyss Institute at Harvard University. Co-founded by Sukanya Punthambaker, Vaskar Gnyawali, George Church, Don Ingber, Alba Tull, Kent Wakeford, and Ben Lamm.

Headquarters
Boston, Massachusetts, United States
Industry
Biotechnology Research
Founded
2024
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

Breaking Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data and 2 with phone data in the visible sample.

Breaking People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Breaking Workforce Composition

Seniority breakdown across 3 visible profiles.

Individual contributor
3

Compare Similar Companies to Breaking

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Vertex Pharmaceuticals Biotechnology Research 6.09K View company
Twist Bioscience Biotechnology Research 1.14K View company
Ginkgo Bioworks, Inc. Biotechnology Research 769 View company
Wyss Institute at Harvard University Biotechnology Research 391 View company
Colossal Biosciences Biotechnology Research 202 View company
Mammoth Biosciences Biotechnology Research 180 View company
Caribou Biosciences Biotechnology Research 137 View company
eGenesis, Inc. Biotechnology Research 133 View company
Form Bio Software Development 43 View company
Eugit Therapeutics Biotechnology Research 2 View company